Information  X 
Enter a valid email address

Evgen Pharma PLC Ord 0.25P (EVG)

Date Time Source Announcement
10 Dec 2018 3:00 pm
RNS
Nominated Adviser Status
04 Dec 2018 7:00 am
RNS
Poster Presentation of SFX-01 and Trial Update
03 Dec 2018 7:00 am
RNS
Notification of Half Year Results
19 Nov 2018 7:00 am
RNS
Investor Presentation in Manchester
08 Nov 2018 7:00 am
RNS
Directorate Changes
23 Oct 2018 9:57 am
RNS
Holding(s) in Company
18 Oct 2018 7:00 am
RNS
Placing
18 Sep 2018 7:00 am
RNS
Investor Symposium
11 Sep 2018 7:00 am
RNS
Notice of Investor Symposium
26 Jul 2018 3:22 pm
RNS
Result of AGM
  7:00 am
RNS
AGM Statement
25 Jul 2018 7:00 am
RNS
Final Patient Recruited in STEM Phase IIa Trial
10 Jul 2018 11:00 am
RNS
Grant of share options, issue of equity and TVR
29 Jun 2018 10:45 am
EQS
Evgen Pharma (EVG): 2018, a pivotal year
21 Jun 2018 12:30 pm
RNS
Posting of Annual Report and AGM Notice
13 Jun 2018 2:14 pm
EQS
Evgen Pharma (EVG): Encouraging interim data from the STEM trial
  7:00 am
RNS
Full Year Results
11 Jun 2018 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
Interim Update on STEM Trial
07 Jun 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
30 May 2018 7:00 am
RNS
Notification of Preliminary Results
15 May 2018 11:00 am
RNS
Price Monitoring Extension
14 May 2018 7:00 am
RNS
Upcoming Investor Presentations
02 May 2018 7:00 am
RNS
Grant of further European patent
26 Apr 2018 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
24 Apr 2018 7:00 am
RNS
Presentation at World Orphan Drug Congress USA
20 Mar 2018 7:00 am
RNS
Research Collaboration with Imperial College
05 Mar 2018 7:00 am
RNS
Update on Novel Sulforaphane Analogues
15 Jan 2018 7:00 am
RNS
Poster Presentation of SFX-01 Mechanistic Data
10 Jan 2018 4:31 pm
RNS
Notification of Major Interest in Shares
05 Jan 2018 9:49 am
RNS
Notification of Major Interest in Shares
  9:48 am
RNS
Notification of Major Interest in Shares
02 Jan 2018 5:44 pm
RNS
Total Voting Rights
28 Dec 2017 11:49 am
RNS
Result of General Meeting
22 Dec 2017 10:10 am
RNS
Grant of Options
13 Dec 2017 7:00 am
RNS
Collaboration with King's College London
11 Dec 2017 7:15 am
RNS
Hardman Res.: Funded to the end of Phase II trials
08 Dec 2017 7:15 am
RNS
Placing and Notice of General Meeting
  7:00 am
RNS
Interim Results
23 Nov 2017 11:05 am
RNS
Second Price Monitoring Extn
  11:00 am
RNS
Price Monitoring Extension
04 Oct 2017 7:00 am
RNS
First European Patent Grant
31 Aug 2017 7:00 am
RNS
Issue of Equity and Total Voting Rights
02 Aug 2017 1:00 pm
RNS
SFX-01 data published in Peer Reviewed Journal
27 Jul 2017 7:00 am
RNS
Result of AGM
26 Jul 2017 7:00 am
RNS
AGM Statement
11 Jul 2017 12:30 pm
RNS
Charity-funded Study of SFX-01 in TNBC
21 Jun 2017 10:00 am
RNS
Posting of Annual Report and AGM Notice
  7:15 am
RNS
Hardman Research: Making clinical progress
13 Jun 2017 7:00 am
RNS
Full Year Results
01 Jun 2017 7:00 am
RNS
Compassionate Use Programme and Trials Update
25 May 2017 7:00 am
RNS
Notice of Preliminary Results
03 Apr 2017 2:15 pm
RNS
Directorate Change
28 Mar 2017 2:45 pm
RNS
Further US Patent Grant
06 Mar 2017 7:00 am
RNS
Issue of Equity, PDMR Shareholding and TVR
14 Feb 2017 1:30 pm
RNS
Patent Grant in the United States
13 Feb 2017 7:00 am
RNS
Services Agreement with APTrans
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t